Results 81 to 90 of about 6,199 (251)
A new supramolecular complex (I) between the tetraphosphonate cavitand Tiiii[C3H7,CH3,C6H5] [systematic name: 2,8,14,20-tetrapropyl-5,11,17,23-tetramethyl-6,10:12,16:18,22:24,4-tetrakis(phenylphosphonato-O,O′)resorcin[4]arene] and mephedrone hydrochoride
Elisa Biavardi, Chiara Massera
doaj +1 more source
The list of pharmacological agents that can modify the gut microbiome or be modified by it continues to grow at a high rate. The greatest amount of attention on drug-gut microbiome interactions has been directed primarily at pharmaceuticals used to treat
Mariana Angoa-Pérez +6 more
doaj +1 more source
The novel psychoactive substances epidemic: A scientometric perspective
The unprecedented proliferation of novel psychoactive substances (NPS) in the illicit drug market has been a public health concern since their emergence in the 2000s.
Michelle Jin Yee Neoh +5 more
doaj +1 more source
Novel Psychoactive Substances: : the pharmacology of stimulants and hallucinogens [PDF]
This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Clinical Pharmacology, on March 2016, available online at doi: : http://www.tandfonline.com/doi/full/10.1586/17512433.2016.1167597.There are increasing levels ...
Corkery JM +11 more
core +3 more sources
4-methylmethcathinone (mephedrone) has emerged in drug seizures as a new psychoactive substance (NPS) causing a public health risk of global concern. Currently, there are no commercial microfluidic devices for the selective detection of mephedrone and so
L. McNeill +8 more
semanticscholar +1 more source
This cross‐sectional fMRI study compared experienced psychedelic users and matched nonusers on behavioral and neural responses to emotional facial expressions. Findings reveal neurofunctional differences between groups in emotional reactivity, highlighting both similarities and important distinctions in the long‐term effects of naturalistic versus ...
Paweł Orłowski +2 more
wiley +1 more source
Voltammetric Analysis of New Psychoactive Substances
New Psychoactive Substances (NPS) are synthetic drugs that create similar effects as various narcotic drugs and psychotropic substances. Different NPS such as mephedrone, synthacaine, synthetic cannabinoids, etc. are available today which are sold across
Ketan Patil, Astha Pandey
doaj +1 more source
Closing Evidence Gaps on the Prevalence and Harms of New Psychoactive Substances in Scotland [PDF]
This paper considers the state of knowledge on New Psychoactive Substances (NPS) in Scotland, with a focus on prevalence and harms and puts forward proposals which may assist in closing existing evidence ...
Gillies, Allan
core
Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA) [PDF]
A decline in 3,4-methylenedioxy-N-methylamphetamine (MDMA) use in Adelaide, Australia from 2009 to 2010 was confirmed by us previously. Reports suggested that the shortage in MDMA supply was associated with an increased prevalence of other synthetic ...
Chen, C. +3 more
core +1 more source
Many novel psychoactive substances (NPS) have entered the recreational drug scene in recent years, yet the problems they cause are similar to those found with established drugs.
Andrew C. Parrott
doaj +1 more source

